Market: NYSE |
Currency: USD
Address: 11 Huron Drive
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
📈 Allurion Technologies Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$8.38
-
Upside/Downside from Analyst Target:
273.88%
-
Broker Call:
6
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
10-25%
-
Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
2025-11-13
-
EPS Estimate:
-2.45
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2025 |
- |
$0.040000 |
- |
2025-01-03 |
- |
Stock split |
|
Total Amount for 2025: $0.040000 |
📅 Earnings & EPS History for Allurion Technologies Inc.
| Date | Reported EPS |
|---|
| 2025-11-13 (estimated upcoming) | - |
| 2025-08-19 | -0.87 |
| 2025-05-14 | -1.23 |
| 2025-03-26 | -7.95 |
| 2024-11-13 | -4.54 |
| 2024-08-13 | 3.42 |
| 2024-05-14 | 2.75 |
| 2024-03-21 | -10 |
📰 Related News & Research
No related articles found for "allurion technologies".
